Safety Shot Inc (SHOT)
USD 0.45
(7.25%)
USD 0.45
(7.25%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 12.1 Million USD | -3.25% |
| 2022 | 12.51 Million USD | -27.68% |
| 2021 | 17.3 Million USD | 210.37% |
| 2020 | 5.57 Million USD | 513.64% |
| 2019 | 908.71 Thousand USD | 153.55% |
| 2018 | 358.4 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 8.51 Million USD | -33.75% |
| 2024 Q1 | 12.85 Million USD | 138.83% |
| 2023 Q1 | 1.49 Million USD | -78.33% |
| 2023 Q3 | 4.18 Million USD | 109.26% |
| 2023 FY | 12.3 Million USD | -1.65% |
| 2023 Q4 | 5.38 Million USD | 28.66% |
| 2023 Q2 | 1.99 Million USD | 33.56% |
| 2022 FY | 12.51 Million USD | -27.68% |
| 2022 Q4 | 6.9 Million USD | 214.4% |
| 2022 Q3 | 2.19 Million USD | 57.14% |
| 2022 Q2 | 1.39 Million USD | -29.37% |
| 2022 Q1 | 1.97 Million USD | -71.61% |
| 2021 Q3 | 3.6 Million USD | -5.99% |
| 2021 Q4 | 6.96 Million USD | 93.11% |
| 2021 FY | 17.3 Million USD | 210.37% |
| 2021 Q1 | 2.88 Million USD | -24.5% |
| 2021 Q2 | 3.83 Million USD | 32.93% |
| 2020 Q4 | 3.82 Million USD | 488.16% |
| 2020 Q2 | 618.11 Thousand USD | 28.17% |
| 2020 Q1 | 482.25 Thousand USD | -24.39% |
| 2020 FY | 5.57 Million USD | 513.64% |
| 2020 Q3 | 650.41 Thousand USD | 5.23% |
| 2019 Q1 | 73.54 Thousand USD | 0.0% |
| 2019 Q4 | 637.79 Thousand USD | 394.5% |
| 2019 Q3 | 128.97 Thousand USD | 88.54% |
| 2019 FY | 908.71 Thousand USD | 153.55% |
| 2019 Q2 | 68.4 Thousand USD | -6.98% |
| 2018 FY | 358.4 Thousand USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Bright Green Corporation | 8.25 Million USD | -46.733% |
| Alpha Teknova, Inc. | 45.85 Million USD | 73.594% |
| ANI Pharmaceuticals, Inc. | 195.98 Million USD | 93.821% |
| Aquestive Therapeutics, Inc. | 44.85 Million USD | 73.002% |
| Collegium Pharmaceutical, Inc. | 159.2 Million USD | 92.394% |
| Cosmos Health Inc. | 26.18 Million USD | 53.746% |
| Journey Medical Corporation | 54.59 Million USD | 77.819% |
| Embecta Corp. | 528.4 Million USD | 97.708% |
| Esperion Therapeutics, Inc. | 271.89 Million USD | 95.546% |
| Dynavax Technologies Corporation | 219.14 Million USD | 94.474% |
| Intra-Cellular Therapies, Inc. | 590 Million USD | 97.948% |
| Pacira BioSciences, Inc. | 326.37 Million USD | 96.29% |
| PainReform Ltd. | 9.58 Million USD | -26.353% |
| Sunshine Biopharma, Inc. | 13.12 Million USD | 7.732% |
| Sunshine Biopharma, Inc. | 13.12 Million USD | 7.732% |
| SCYNEXIS, Inc. | 51.84 Million USD | 76.644% |
| China SXT Pharmaceuticals, Inc. | 3.06 Million USD | -294.557% |
| Procaps Group, S.A. | 199.47 Million USD | 93.929% |
| Theratechnologies Inc. | 72.75 Million USD | 83.356% |
| Harrow Health, Inc. | 89.97 Million USD | 86.541% |
| Sonoma Pharmaceuticals, Inc. | 9.44 Million USD | -28.199% |
| Biofrontera Inc. | 39.95 Million USD | 69.695% |
| DURECT Corporation | 43.71 Million USD | 72.299% |
| Supernus Pharmaceuticals, Inc. | 529.01 Million USD | 97.711% |
| Cronos Group Inc. | 96.7 Million USD | 87.478% |
| OptiNose, Inc. | 85.1 Million USD | 85.77% |
| Ironwood Pharmaceuticals, Inc. | 232.12 Million USD | 94.783% |
| Kala Pharmaceuticals, Inc. | 39.15 Million USD | 69.071% |
| RedHill Biopharma Ltd. | -9.56 Million USD | 226.657% |
| Organogenesis Holdings Inc. | 314.13 Million USD | 96.145% |
| Guardion Health Sciences, Inc. | 9.73 Million USD | -24.447% |
| Cumberland Pharmaceuticals Inc. | 43.04 Million USD | 71.864% |
| Radius Health, Inc. | 265.92 Million USD | 95.446% |
| Universe Pharmaceuticals INC | 13.84 Million USD | 12.514% |
| ProPhase Labs, Inc. | 37.85 Million USD | 68.008% |
| Phibro Animal Health Corporation | 260.29 Million USD | 95.348% |
| Procaps Group S.A. | 187.24 Million USD | 93.533% |
| Alvotech | 285.43 Million USD | 95.758% |
| TherapeuticsMD, Inc. | 9.82 Million USD | -23.254% |
| Viatris Inc. | 5.96 Billion USD | 99.797% |
| Rockwell Medical, Inc. | 15.37 Million USD | 21.233% |
| Aytu BioPharma, Inc. | 59.84 Million USD | 79.763% |
| SIGA Technologies, Inc. | 22.04 Million USD | 45.063% |
| Tilray Brands, Inc. | 251.35 Million USD | 95.182% |
| Lifecore Biomedical, Inc. | 49.03 Million USD | 75.305% |
| Shineco, Inc. | 17.94 Million USD | 32.529% |
| PetIQ, Inc. | 192.72 Million USD | 93.717% |
| Regencell Bioscience Holdings Limited | 3.99 Million USD | -203.415% |
| Incannex Healthcare Limited | 30.05 Million USD | 59.706% |
| Neurocrine Biosciences, Inc. | 1.59 Billion USD | 99.241% |
| Alimera Sciences, Inc. | 62.64 Million USD | 80.668% |
| Silver Spike Investment Corp. | 762.49 Thousand USD | -1488.173% |
| Assertio Holdings, Inc. | 368.58 Million USD | 96.715% |
| Shuttle Pharmaceuticals Holdings, Inc. | 5.88 Million USD | -105.752% |
| Petros Pharmaceuticals, Inc. | 17.8 Million USD | 32.001% |
| Clever Leaves Holdings Inc. | 21.16 Million USD | 42.795% |
| Cyclo Therapeutics, Inc. | 21.04 Million USD | 42.45% |
| Avadel Pharmaceuticals plc | 164.96 Million USD | 92.659% |
| Hempacco Co., Inc. | 7.59 Million USD | -59.413% |
| Talphera, Inc. | 11.99 Million USD | -0.965% |
| Alvotech | 285.43 Million USD | 95.758% |
| Eagle Pharmaceuticals, Inc. | 140.71 Million USD | 91.394% |
| Lantheus Holdings, Inc. | 344.9 Million USD | 96.489% |
| Currenc Group, Inc. | 24 Million USD | 49.547% |
| Kamada Ltd. | 45.42 Million USD | 73.342% |
| Indivior PLC | 911 Million USD | 98.671% |
| Evoke Pharma, Inc. | 12.4 Million USD | 2.417% |
| Flora Growth Corp. | 10.57 Million USD | -14.469% |
| Cyclo Therapeutics, Inc. | 21.04 Million USD | 42.45% |
| Evolus, Inc. | 189.75 Million USD | 93.618% |
| HUTCHMED (China) Limited | 436.23 Million USD | 97.224% |
| Amphastar Pharmaceuticals, Inc. | 154.13 Million USD | 92.143% |
| Akanda Corp. | 3.48 Million USD | -247.629% |